• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOLTON MEDICAL, INC. TREO ABDOMINAL STENT-GRAFT SYSTEM; STENT, ENDOVASCULAR GRAFT, AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOLTON MEDICAL, INC. TREO ABDOMINAL STENT-GRAFT SYSTEM; STENT, ENDOVASCULAR GRAFT, AORTIC Back to Search Results
Catalog Number 28-B2-26-100U
Device Problems Leak/Splash (1354); Activation, Positioning or Separation Problem (2906); Difficult to Open or Close (2921)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/11/2022
Event Type  Injury  
Event Description
Endoleak (type 1a): imaging performed prior to an evar was plain ct only, no contrast-enhanced ct was performed in view of the patient's low renal function.During the procedure, the ra was confirmed by angiography using contrast medium, and carbon dioxide angiography was used to confirm the bifurcation of the internal and external iliac arteries.In the evar, the treo main bifurcated stent graft was deployed from just below the lowest renal artery and two excluders were used for the legs of the treo.The procedure was completed successfully without any leakage.However, postoperative abdominal ultrasonography revealed a suspected type 1a endoleak.Post-deployment plain ct showed that the proximal portion of the treo stent-graft was not open completely.The preoperative plain ct revealed thin calcification-like substance in the aorta, and the neck of the aneurysm was presumed to have been originally dissected; it was suggested that the endoleak might have occurred due to insufficient deployment of the second stent in the treo stent-graft.On (b)(6) 2022, additional treatment was performed.No endoleak was observed by ultrasonography, however, contrast enhanced ct revealed a type 1a endoleak.Though it was dissection, by applying force to the neck of the treo stent-graft using a balloon the second stent was opened, and the shape of the neck was successfully corrected.Subsequently, the procedure was completed with the touch-up only.Comment from the physician: the first stent was fully open, however, the graft fabric of the first stent was not fully opened because it was pulled by the second stent, which was not fully opened.Ancillary devices used: excluder141000, excluder121200.Operation type: evar.(tc#:(b)(4)).Patient outcome - "no health damage to the patient.".
 
Event Description
Endoleak (type 1a): imaging performed prior to an evar was plain ct only, no contrast-enhanced ct was performed in view of the patient's low renal function.During the procedure, the ra was confirmed by angiography using contrast medium, and carbon dioxide angiography was used to confirm the bifurcation of the internal and external iliac arteries.In the evar, the treo main bifurcated stent graft was deployed from just below the lowest renal artery and two excluders were used for the legs of the treo.The procedure was completed successfully without any leakage.However, postoperative abdominal ultrasonography revealed a suspected type 1a endoleak.Post-deployment plain ct showed that the proximal portion of the treo stent-graft was not open completely.The preoperative plain ct revealed thin calcification-like substance in the aorta, and the neck of the aneurysm was presumed to have been originally dissected; it was suggested that the endoleak might have occurred due to insufficient deployment of the second stent in the treo stent-graft.On (b)(6), 2022, additional treatment was performed.No endoleak was observed by ultrasonography, however, contrast enhanced ct revealed a type 1a endoleak.Though it was dissection, by applying force to the neck of the treo stent-graft using a balloon the second stent was opened, and the shape of the neck was successfully corrected.Subsequently, the procedure was completed with the touch-up only.Comment from the physician: the first stent was fully open, however, the graft fabric of the first stent was not fully opened because it was pulled by the second stent, which was not fully opened.Ancillary devices used: - excluder141000.- excluder121200.Operation type: evar.(tc#:(b)(4)).Patient outcome - "no health damage to the patient.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TREO ABDOMINAL STENT-GRAFT SYSTEM
Type of Device
STENT, ENDOVASCULAR GRAFT, AORTIC
Manufacturer (Section D)
BOLTON MEDICAL, INC.
799 international parkway
sunrise FL 33325
Manufacturer Contact
megan indeglia
799 international parkway
sunrise, FL 33325
9548389699
MDR Report Key13387295
MDR Text Key288471161
Report Number2247858-2022-00014
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P190015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/16/2024
Device Catalogue Number28-B2-26-100U
Device Lot Number2104060131
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/13/2022
Initial Date FDA Received01/28/2022
Supplement Dates Manufacturer Received01/13/2022
Supplement Dates FDA Received05/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/17/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-